American Conference Institute’s 3nd West Coast Edition

Paragraph IV Disputes

Tuesday, December 04 to Wednesday, December 05, 2012
Hotel Nikko, San Francisco, CA
The must-attend event for litigators from brand name and generic companies to share insights into increasingly high-stakes and complicated Hatch-Waxman litigation.

With hundreds of billions of dollars at stake as blockbuster drugs go off patent in 2014, Hatch-Waxman litigation will only intensify. Brand name manufacturers are struggling to fill a drying pipeline and extend patent life through other statutory and regulatory conventions.  Meanwhile, generics eye the ultimate Hatch-Waxman prize of 180-day exclusivity— knowing that such opportunities in the future may be short-lived as there will be few patented drug products worth coveting. 

The monetary ante combined with constantly evolving case law including Therasense, Prometheus, Caraco, Global Tech, Akamai and McKesson and legislative developments including long-awaited patent reform create more questions and will spawn more litigation as well.

At American Conference Institute’s 3nd Annual West Coast edition of its acclaimed Paragraph IV Disputes conference, an experienced faculty of renowned litigators and judges will guide you through every stage of a Paragraph IV challenge. They will help you formulate the offensive moves and defensive plays for the next round in the no-holds barred fight for pharmaceutical product market share. Additionally, in the wake of major developments in pay-for-delay, learn what the Federal Trade Commission deems foul and fair in the settlement of Paragraph IV disputes in order to draft and structure a settlement that will receive FTC approval.

At this industry-leading conference, our West Coast delegates will gain the tools to advance a novel claim or defense to protect patents and market share. They will have access to the expertise of trial leading patent counsel from generic and branded companies. They will also have the opportunity to hear from judges – who have experienced the intricacies of Hatch Waxman litigation first hand. Featuring an up-to-the-minute analysis of the latest game-changing case law developments regarding inequitable conduct, inducement of infringement and the standard of invalidity, this conference will give our attendees the strategies they need to help both brand name and generic companies protect market share and ultimately profits.

In this costly and ruthless endgame, not a moment can be lost. Don’t delay- register now by calling 1-888-224-2480, faxing your registration form to 877-927-1563, or logging onto to